title: Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.
abstract: Minimally invasive surgery (MIS) is increasingly being used to treat uterine fibroids because of the significant patient and societal benefits of these techniques over traditional laparotomy. Morcellation affords the removal of large fibroids in MIS but carries the risk of disseminating occult malignant tissue. The benefits of MIS for treating fibroids must be carefully weighed against its risks of morcellation.
authors.affiliation: Department of Obstetrics & Gynecology, Division of Minimally Invasive Gynecologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Siedhoff
authors.affiliation: Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
authors.forename: Kenneth H
authors.initials: KH
authors.lastname: Kim
mesh_terms: D005260:Female; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D007813:Laparotomy; D007889:Leiomyoma / Q000473:pathology* / Q000601:surgery*; D000069577:Morcellation / Q000009:adverse effects* / Q000295:instrumentation; D009366:Neoplasm Seeding; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D014481:United States; D014594:Uterine Neoplasms / Q000473:pathology* / Q000601:surgery*
keywords: fibroids; hysterectomy; leiomyosarcoma; morcellation; myomectomy